Comparability Protocols for Human Drugs and Biologics: Guidance for Industry

Posted on Categories News You Can Use from MWATags , , ,

How do you handle post-approval changes to your products?  New draft FDA guidance document establishes a framework to ensure you effectively use your product and process knowledge and understanding to prepare a Comparability Protocol that employs the tools in ICH Q8 to Q11.  It also provides guidance on a robust control strategy, incorporates risk management over the product’s life cycle and describes elements of an effective pharmaceutical quality system.

Learn more and download the guidance here.

Sign up for the latest news in the industry!